NRx Pharmaceuticals Announces Closing of $25 Million Private Placement Priced at a Premium to Market Under Nasdaq Rules

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

Delaware ,United States ,Israel ,Daniele Troy ,Eric Goldstein ,Jack Hirschfield ,Chaim Hurvitz ,Sherry Glied ,Jonathan Javitt ,Nrx Pharmaceuticals ,Phd Us Army ,Nasdaq ,Israel Ministry Of Defense ,Novartis ,Pfizer ,Prnewswire Nrx Pharmaceuticals Nasdaq ,Source Nrx Pharmaceuticals ,Allergan ,Us Department Of Health ,Hc Wainwright Co ,Head Of External Affairs ,Israel Institute For Biological Research ,Human Services ,Biomedical Advanced Research ,Drug Administration ,United States National Security Advisor ,Development Authority ,Nrx Pharmaceuticals Inc ,Teva International Group ,Us Department Of Defense ,Us National Institutes Of Health ,Securities Act ,Israel Institute ,Biological Research ,Israel Ministry ,Fast Track ,Medical Countermeasures ,Breakthrough Therapy Designation ,Special Protocol Agreement ,Biomarker Letter ,Prof Jonathan Javitt ,Chief Counsel ,United States National Security ,Securities Litigation Reform Act ,External Affairs ,Business ,Pr Newswire ,